Revlimid Pricing: Why Cancer Pill Costs $900 in US, $0.37 in India
The cost of Revlimid, a crucial cancer treatment, soars to nearly $1,000 per daily capsule in the U.S. but can be as low as $0.37 in India, thanks to regulator…
Gaddafi's UN Speech: A 2009 Critique of Pharmaceutical Profits
Muammar Gaddafi's 2009 UN speech delivered a critical critique against the pharmaceutical industry and the profit-driven nature of global healthcare, advocatin…
Obesity Drug Market Set for 5x Growth by 2030, Reaching $77 Billion
The obesity drug market is anticipated to surge fivefold by 2030, reaching $77 billion, driven by escalating obesity rates, improved pharmaceutical research, a…
Pharma R&D Investment: Oncology Leads Despite Heart Disease
Pharmaceutical research and development (R&D) investments are heavily concentrated in oncology, with nearly 10,000 drugs in the pipeline. This focus is driven…
Top Weight Loss Drugs: Market Share & Growth
The weight loss drug market, valued at $58 billion, is booming with Novo Nordisk and Eli Lilly leading the way. Their GLP-1 drugs, Ozempic and Wegovy, are driv…